Outlook Therapeutics, Inc. - Se
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $53,126,382.
Profit Margin
| 2014 | 9.05M | -13.73M | -151.73% |
|---|---|---|---|
| 2015 | 5.21M | -47.39M | -908.05% |
| 2016 | 5.21M | -47.39M | -908.05% |
| 2017 | 3.81M | -38.84M | -1019.26% |
| 2018 | 3.81M | -38.84M | -1019.26% |
| 2019 | 8.14M | -34.52M | -423.81% |
| 2020 | 0 | -35.23M | |
| 2021 | 0 | -53.16M | |
| 2023 | 0 | -58.98M |
OTLKW Income Statement (2014 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 0 | 0 | 0 | 8.14M | 3.81M | 3.81M | 5.21M | 5.21M | 9.05M |
Cost of revenue | 44.18K | 0 | 554.06K | 0 | 0 | 23.80K | 0 | 38.87K | 14.12K |
Gross profit | -44.18K | 0 | -554.06K | 8.14M | 3.81M | 3.78M | 5.21M | 5.18M | 9.03M |
Operating exp. | |||||||||
Research and development | 26.45M | 38.95M | 26.34M | 23.80M | 23.80M | 23.80M | 38.87M | 38.87M | 14.12M |
Selling and marketing | 0 | 0 | -1.89M | 0 | 0 | -2.69M | 0 | 0 | 0 |
Total operating expenses | 53.12M | 51.72M | 36.31M | 44.44M | 39.69M | 39.69M | 51.78M | 51.78M | 21.44M |
Operating income | -53.12M | -51.72M | -36.84M | -36.29M | -29.64M | -35.88M | -51.75M | -46.56M | -12.39M |
Other income (expenses), net | -5.85M | -1.43M | -1.67M | -1.63M | -8.70M | -2.46M | 4.17M | -2.29M | -901.05K |
Income before tax | -58.97M | -53.16M | -38.51M | -37.93M | -38.34M | -38.34M | -47.58M | -48.85M | -13.29M |
Income tax expense | 2.8K | -498.48K | -3.27M | -3.41M | 501.5K | 501.5K | -190.11K | -190.11K | 439.01K |
Net income | -58.98M | -53.16M | -35.23M | -34.52M | -38.84M | -38.84M | -47.39M | -47.39M | -13.73M |
Earnings per share | |||||||||
Basic EPS | -4.72 | -0.95 | -9.71 | -1.9 | -1.62 | -258.75 | -4.86 | -504.47 | -155.35 |
Diluted EPS | -4.72 | -0.95 | -9.71 | -1.9 | -1.62 | -258.54 | -4.86 | -504.47 | -155.35 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |